Salvage chemotherapy with rituximab DHAP for relapsed non-Hodgkin lymphoma: A phase II trial in the North Central Cancer Treatment Group
- Citation:
- Leuk Lymphoma vol 49 (6) 1074-1080
- Year:
- 2008
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- U10 CA035267, U10 CA052352, U10 CA037417, N01 CA035431, U10 CA035269, CA-37404, U10 CA060276, CA-52352, CA-35195, U10 CA037404, U10 CA035448, U10 CA035195, CA-25224, CA-60276, U10 CA035101, P30 CA015083, U10 CA035415, U10 CA063849, CA-35415, U10 CA035431, CA-37417, CA-35269, CA-35448, CA-35101, U10 CA025224, CA-15083, CA-35267, CA-63849, N01 CA015083
- Corr. Author:
- Authors:
- Thomas E. Witzig Susan M. Geyer Paul J. Kurtin Joseph P. Colgan David J. Inwards Ivana N. M. Micallef Betsy R. LaPlant John C. Michalak Muhammad Salim Robert J. Dalton Dennis F. Moore Craig B. Reeder
- Networks:
- Study
- NCCTG-N9981
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- Non-Hodgkin lymphoma , salvage chemotherapy , transplant , rituximab